首页> Trials> Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial.

Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial.

导出 OA

翻译打印收藏纠错

第一作者： Spoorthy,Kulkarni

第一单位： Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0QQ, UK. Spoorthy.kulkarni@addenbrookes.nhs.uk.

作者： Spoorthy,Kulkarni ^[1] ; Marie,Fisk ^[2] ; Michalis,Kostapanos ^[2] ; Edward,Banham-Hall ^[2] ; Simon,Bond ^[2] ; Elena,Hernan-Sancho ^[2] ; Sam,Norton ^[3] ; Joseph,Cheriyan ^[2] ; Andrew,Cope ^[3] ; James,Galloway ^[3] ; Frances,Hall ^[2] ; David,Jayne ^[4] ; Ian B,Wilkinson ^[4]

作者单位： Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0QQ, UK. Spoorthy.kulkarni@addenbrookes.nhs.uk. ^[1] Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0QQ, UK. ^[2] King's College London, Strand, London, WC2R 2LS, UK. ^[3] University of Cambridge, The Old Schools, Trinity Lane, Cambridge, CB2 1TN, UK. ^[4]

关键词 Adaptive trial Baricitinib COVID-19 Open-label Protocol Randomised controlled trial Ravulizumab Repurposed drugs